RU2011152105A - Составы таблеток 3-цианохинолина и их применение - Google Patents
Составы таблеток 3-цианохинолина и их применение Download PDFInfo
- Publication number
- RU2011152105A RU2011152105A RU2011152105/15A RU2011152105A RU2011152105A RU 2011152105 A RU2011152105 A RU 2011152105A RU 2011152105/15 A RU2011152105/15 A RU 2011152105/15A RU 2011152105 A RU2011152105 A RU 2011152105A RU 2011152105 A RU2011152105 A RU 2011152105A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- weight
- amount
- approximately
- microcrystalline cellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22253709P | 2009-07-02 | 2009-07-02 | |
| US61/222,537 | 2009-07-02 | ||
| PCT/US2010/040555 WO2011002857A2 (en) | 2009-07-02 | 2010-06-30 | 3-cyanoquinoline tablet formulations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2011152105A true RU2011152105A (ru) | 2013-08-10 |
Family
ID=42732381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011152105/15A RU2011152105A (ru) | 2009-07-02 | 2010-06-30 | Составы таблеток 3-цианохинолина и их применение |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2448563A2 (es) |
| JP (1) | JP2011012063A (es) |
| KR (1) | KR20120046216A (es) |
| CN (1) | CN102470109A (es) |
| AR (1) | AR077546A1 (es) |
| AU (1) | AU2010266342A1 (es) |
| BR (1) | BRPI1015941A2 (es) |
| CA (1) | CA2766067A1 (es) |
| IL (1) | IL217298A0 (es) |
| MX (1) | MX2012000048A (es) |
| RU (1) | RU2011152105A (es) |
| SG (1) | SG177309A1 (es) |
| TW (1) | TW201113050A (es) |
| WO (1) | WO2011002857A2 (es) |
| ZA (1) | ZA201200366B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101313702B1 (ko) | 2005-02-03 | 2013-10-04 | 와이어쓰 | 제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물 |
| EP3488866A1 (en) | 2005-11-04 | 2019-05-29 | Wyeth LLC | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| EP3443961B1 (en) | 2008-06-17 | 2020-10-28 | Wyeth LLC | Antineoplastic combinations containing hki-272 and vinorelbine |
| BRPI0916694B1 (pt) | 2008-08-04 | 2021-06-08 | Wyeth Llc | uso de neratinibe em combinação com capecitabina para tratar câncer de mama metastático de erbb-2 positivo, kit e produto compreendendo os mesmos |
| CA2755789C (en) | 2009-04-06 | 2016-01-19 | Wyeth Llc | Treatment regimen utilizing neratinib for breast cancer |
| PT2498756T (pt) | 2009-11-09 | 2019-11-26 | Wyeth Llc | Formulações de comprimidos de maleato de neratinib |
| EP2498751B1 (en) | 2009-11-09 | 2019-04-03 | Wyeth LLC | Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| CN104447541A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 博舒替尼化合物 |
| CN105384686B (zh) * | 2014-09-04 | 2019-07-26 | 连云港润众制药有限公司 | 一种博舒替尼结晶方法 |
| JP2019513754A (ja) * | 2016-04-08 | 2019-05-30 | 塩野義製薬株式会社 | 安定化した固形製剤 |
| JP7086938B2 (ja) | 2017-03-31 | 2022-06-20 | 日精エー・エス・ビー機械株式会社 | 樹脂製容器 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| CA2476587C (en) * | 2002-02-26 | 2010-05-04 | Astrazeneca Ab | Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| MXPA06001590A (es) | 2003-08-19 | 2006-05-19 | Wyeth Corp | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos. |
| JP4834553B2 (ja) * | 2004-09-17 | 2011-12-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
| JP2009500332A (ja) * | 2005-07-01 | 2009-01-08 | ワイス | ４−［（２，４−ジクロロ−５−メトキシフェニル）アミノ］−６−メトキシ−７−［３−（４−メチル−１−ピペラジニル）プロポキシ］−３−キノリンカルボニトリルの結晶形態およびその調製方法 |
| WO2008053295A2 (en) * | 2006-10-30 | 2008-05-08 | Wockhardt Research Centre | Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid |
| CN101224185A (zh) * | 2007-12-11 | 2008-07-23 | 山东蓝金生物工程有限公司 | 一种治疗实体肿瘤的伯舒替尼缓释植入剂 |
-
2010
- 2010-06-30 AU AU2010266342A patent/AU2010266342A1/en not_active Abandoned
- 2010-06-30 KR KR1020127002851A patent/KR20120046216A/ko not_active Application Discontinuation
- 2010-06-30 EP EP10732568A patent/EP2448563A2/en not_active Withdrawn
- 2010-06-30 WO PCT/US2010/040555 patent/WO2011002857A2/en active Application Filing
- 2010-06-30 SG SG2011094950A patent/SG177309A1/en unknown
- 2010-06-30 CN CN2010800294791A patent/CN102470109A/zh active Pending
- 2010-06-30 MX MX2012000048A patent/MX2012000048A/es not_active Application Discontinuation
- 2010-06-30 BR BRPI1015941A patent/BRPI1015941A2/pt not_active Application Discontinuation
- 2010-06-30 RU RU2011152105/15A patent/RU2011152105A/ru unknown
- 2010-06-30 CA CA2766067A patent/CA2766067A1/en not_active Abandoned
- 2010-07-01 TW TW099121740A patent/TW201113050A/zh unknown
- 2010-07-01 JP JP2010151063A patent/JP2011012063A/ja not_active Withdrawn
- 2010-07-02 AR ARP100102373A patent/AR077546A1/es not_active Application Discontinuation
-
2011
- 2011-12-29 IL IL217298A patent/IL217298A0/en unknown
-
2012
- 2012-01-17 ZA ZA2012/00366A patent/ZA201200366B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2766067A1 (en) | 2011-01-06 |
| AU2010266342A1 (en) | 2012-01-19 |
| ZA201200366B (en) | 2012-10-31 |
| CN102470109A (zh) | 2012-05-23 |
| WO2011002857A3 (en) | 2011-03-10 |
| JP2011012063A (ja) | 2011-01-20 |
| KR20120046216A (ko) | 2012-05-09 |
| IL217298A0 (en) | 2012-02-29 |
| BRPI1015941A2 (pt) | 2016-04-19 |
| AR077546A1 (es) | 2011-09-07 |
| SG177309A1 (en) | 2012-02-28 |
| TW201113050A (en) | 2011-04-16 |
| MX2012000048A (es) | 2012-01-27 |
| EP2448563A2 (en) | 2012-05-09 |
| WO2011002857A2 (en) | 2011-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| HRP20192026T4 (hr) | Formulacija tableta od neratinib maleata | |
| FI3265084T3 (fi) | Brutonin tyrosiinikinaasin estäjän lääkeformulaatioita | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| NZ729172A (en) | Combination formulation of two antiviral compounds | |
| NZ753904A (en) | Compositions and methods for treating anemia | |
| BRPI0403935B8 (pt) | formas de dosagem de azitromicina com efeitos colaterais reduzidos | |
| NZ592673A (en) | Antisense compositions with enteric coating for treating crohn's disease, colitis and bowel disease | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| WO2012079092A3 (en) | Testosterone undecanoate compositions | |
| RS54329B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS | |
| NZ620879A (en) | A novel formulation of indomethacin | |
| JP2013531041A5 (es) | ||
| RU2011137131A (ru) | Производные 1-аминоалкилциклогексана для лечения тиннитуса, связанного с потерей слуха или незначительной потерей слуха | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| RU2010107843A (ru) | Бупропиона гидробромид и его терапевтические применения | |
| JP2013508289A5 (es) | ||
| BR112012009857A2 (pt) | composições farmacêuticas sólidas contendo um inibidor de integrase | |
| RU2012142811A (ru) | Фармацевтические композиции и пероральные дозированные формы пролекарства леводопы и способы применения | |
| JP2018527305A5 (es) | ||
| RU2013154355A (ru) | Способ лечения мезотелиомы ингибитором рi3к | |
| RU2016117186A (ru) | Комбинированная композиция, содержащая тадалафил и амлодипин | |
| NO20091644L (no) | Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist | |
| HRP20180315T1 (hr) | Čvrsti oblici soli alfa-6-mpeg6-o-hidroksikodona kao opioidni agonisti i njihove upotrebe | |
| EA201170583A1 (ru) | Новая композиция для лечения эссенциальной тромбоцитемии |